[Federal Register Volume 68, Number 42 (Tuesday, March 4, 2003)]
[Notices]
[Page 10272]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-5042]


=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice (03-028)]


Notice of Prospective Patent License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of Prospective Patent License.

-----------------------------------------------------------------------

SUMMARY: NASA hereby gives notice that Critical Care Innovations, Inc., 
having offices in Chantilly, Virginia, has applied for a partially 
exclusive license to practice the invention described and claimed in 
U.S. Patent No. 5,869,238, entitled ``Quantitative Method of Measuring 
Metastatic Activity,'' and in continuations, divisional applications, 
and foreign applications corresponding to this case. The 5,869,238 
patent is assigned to the United States of America as represented by 
the Administrator of the National Aeronautics and Space Administration. 
Written objections to the prospective grant of a license should be sent 
to the Johnson Space Center.

DATES: Responses to this notice must be received by March 19, 2003.

FOR FURTHER INFORMATION CONTACT: James Cate, Patent Attorney, NASA 
Johnson Space Center, Mail Stop HA, Houston, TX 77058-8452; telephone 
(281) 483-1001.

    Dated: February 26, 2003.
Robert M. Stephens,
Deputy General Counsel.
[FR Doc. 03-5042 Filed 3-3-03; 8:45 am]
BILLING CODE 7510-01-P